Concurrent chemoradiotherapy using a single agent for unresectable stage IIi non-small cell lung cancer
Tamura, A.; Mikami, A.; Sagara, Y.; Hebisawa, A.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(11): 1755-1758
2000
ISSN/ISBN: 0385-0684 PMID: 11057330 Document Number: 523498
Document emailed within 1 workday
Related Documents
Hou, H.-l.; Hao, J.-l.; Pang, Q.-s.; Wang, P. 2010: Concurrent chemoradiotherapy for stage IIi non-small cell lung cancer Zhonghua Yi Xue Za Zhi 90(29): 2068-2070Rusch, V.W.; Albain, K.S.; Crowley, J.J.; Rice, T.W.; Lonchyna, V.; McKenna, R.; Livingston, R.B.; Griffin, B.R.; Benfield, J.R. 1993: Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial Journal of Thoracic and Cardiovascular Surgery 105(1): 97
Turrisi, A.T. 1997: Concurrent chemoradiotherapy for limited small-cell lung cancer Oncology 11(9 Suppl 9: 31-37
Lee, H-W.; Choi, J-H.; Lim, H-Y.; Park, J.S.; Kim, H.C.; Kang, S.; Oh, Y.T.; Chun, M.; Sheen, S.S.; Oh, Y.J.; Park, K.J.; Hwang, S.C. 2006: The addition of induction chemotherapy with etoposide, ifosfamide, and cisplatin failed to improve therapeutic outcome of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer -- single institution retrospective analysis Neoplasma 53(1): 30-36
Tamaki, T.; Oura, S.; Yoshimasu, T.; Ota, F.; Nakamura, R.; Shimizu, Y.; Kiyoi, M.; Naito, K.; Hirai, Y.; Okamura, Y. 2008: Histoculture drug response assay guided concurrent chemoradiotherapy for non-small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 61(1): 31-35
Fram, R.; Skarin, A.; Balikian, J.; Amato, D.; Leslie, N.; Malcolm, A.; Frei, E. 1985: Combination chemotherapy followed by radiation therapy in patients with regional stage IIi unresectable non-small cell lung cancer Cancer Treatment Reports 69(6): 587-590
Nakano, K.; Yamamoto, M.; Iwamoto, H.; Hiramoto, T. 2003: Daily low-dose cisplatin plus concurrent high-dose thoracic radiotherapy in elderly patients with locally advanced unresectable non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(9): 1283-1287
Wozniak, A.J. 1999: Single-agent vinorelbine in the treatment of non-small cell lung cancer Seminars in Oncology 26(5 Suppl 16: 62-66; Discussion: 71-72
Le Chevalier, T. 1996: Single-agent activity of gemcitabine in advanced non-small cell lung cancer Seminars in Oncology 23(5 Suppl 10: 36-42
Zhang, Y.-F.; Yu, Y.-F.; Lu, S. 2009: Comparison of single-agent docetaxel versus docetaxel plus platinum combination agent in second-line treatment for advanced non-small cell lung cancer Zhonghua Yi Xue Za Zhi 89(22): 1544-1548
2016: (S040) Nadir White Blood Cell, Absolute Neutrophil, and Absolute Lymphocyte Counts During Concurrent Chemoradiation Therapy Predicted Worse Outcomes in Patients With Limited-Stage Small-Cell Lung Cancer Oncology 30 Suppl
Yamamoto, M.; Furuse, K.; Fukuoka, M.; Kawahara, M.; Arai, R.; Kodama, N.; Takada, M.; Negoro, S.; Matsui, K.; Ryu, S. 1988: Phase Ii studies of a single agent and a cis-platinum-based two-drug combination in patients with non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 487-492
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Bianco, V.; Rozzi, A.; Tonini, G.; Santini, D.; Magnolfi, E.; Vincenzi, B.; D'Angelillo, R.; Marchei, P. 2002: Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase Ii study Anticancer Research 22(5): 3053-3056
Catalano, G.; De Pas, T.; Spaggiari, L.; Gandini, S.; Jereczek-Fossa, B.Alicja.; De Braud, F.; Leo, F.; Veronesi, G.; Orecchia, R. 2008: Three-times daily radiotherapy after chemotherapy in stage III non-small cell lung cancer. Single-institution prospective study Anticancer Research 28(6b): 4121-4127
Manegold, C. 1998: Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer Seminars in Oncology 25(4 Suppl 9: 18-22
Socinski, M.A.; Langer, C.J. 1999: Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer Seminars in Oncology 26(5 Suppl 16: 51-61; Discussion: 71-72
Gridelli, C.; Frontini, L.; Barletta, E.; Rossi, A.; Barzelloni, M.L.; Scognamiglio, F.; Guida, C.; Gatani, T.; Fiore, F.; De Bellis, M.; Marfella, A.; Manzione, L. 2000: Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature Anticancer Research 20(2b): 1077-1084
Iatsenko, L.D. 2007: Results of palliative chemoradiotherapy of advanced small cell lung cancer using polyplatillen Likars'ka Sprava 3: 39-42
Sanada, H.; Hayashi, A.; Tomimitsu, S.; Ikeda, K.; Nakanishi, K.; Hiyama, J.; Hidaka, D.; Sawamoto, R.; Miyagawa, Y.; Misumi, Y.; Fujii, A.; Nakatsubo, S.; Tsuru, M.; Omagari, J.; Koshizuka, H. 2009: Estimation of preoperative induction chemoradiotherapy effectiveness for non small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2012-2015